Chinese biotechnology company Immunochina Pharmaceuticals has raised a RMB$140 million (US$20.4 million) series C round of financing led by a syndicate of Chinese and international investors, according to a statement released on January 22. Investors in the new round include government-backed investment company Shougang Fund, San Francisco-based venture capital firm Sherpa Venture Capital, PayPal’s co-founder […]

Chinese Biotech Firm Immunochina Raises $20M In Series C Round appeared first on China Money Network.